Revelation Biosciences In...
(REVB)
undefined
undefined%
At close: undefined
0.36
0.00%
Pre-market Dec 16, 2024, 04:23 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 11.99M | 5.25M | 1.27M | 4.49M | - |
| Short-Term Investments | - | - | - | 525.29K | - |
| Long-Term Investments | - | - | - | 73.51M | - |
| Other Long-Term Assets | - | - | 0.00 | - | 22.67K |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | 155.82K | 160.30K | 637.34K | 128.00K | - |
| Total Current Assets | 12.15M | 5.41M | 1.91M | 4.62M | - |
| Property-Plant & Equipment | 65.08K | 90.13K | 130.14K | - | - |
| Goodwill & Intangibles | - | - | - | - | - |
| Total Long-Term Assets | 65.08K | 90.13K | 130.14K | 73.51M | 22.67K |
| Total Assets | 12.21M | 5.50M | 2.04M | 4.62M | 22.67K |
| Account Payables | 1.36M | 554.21K | 596.26K | 865.90K | - |
| Deferred Revenue | - | 2.91M | - | - | - |
| Short-Term Debt | - | - | 16.75K | - | - |
| Other Current Liabilities | 4.20M | 3.90M | 1.53M | 342.88K | 26.31K |
| Total Current Liabilities | 5.56M | 4.45M | 2.14M | 1.21M | 26.31K |
| Long-Term Debt | - | - | - | - | - |
| Other Long-Term Liabilities | - | - | - | - | - |
| Total Long-Term Liabilities | - | 554.21K | 2.91M | 2.91M | - |
| Total Liabilities | 5.56M | 4.45M | 2.14M | 1.21M | 26.31K |
| Total Debt | - | - | 16.75K | - | - |
| Common Stock | 265.00 | 683.00 | 2.31K | 2.29K | - |
| Retained Earnings | -25.47M | -25.35M | -14.52M | -2.53M | -3.64K |
| Comprehensive Income | -0.00 | - | -0.00 | - | - |
| Shareholders Equity | 6.65M | 1.05M | -99.47K | 3.41M | -3.64K |
| Total Investments | - | - | - | 525.29K | - |